Microbot Medical Net Income
| MBOT Stock | USD 2.00 0.05 2.44% |
As of the 12th of February 2026, Microbot Medical secures the Mean Deviation of 3.52, downside deviation of 3.95, and Risk Adjusted Performance of 0.024. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Microbot Medical, as well as the relationship between them.
Microbot Medical Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | -13.2 M | -13.8 M | |
| Net Loss | -15.1 M | -15.9 M | |
| Net Loss | (0.66) | (0.69) | |
| Net Income Per E B T | 1.15 | 0.80 |
Microbot | Net Income | Build AI portfolio with Microbot Stock |
The evolution of Net Income for Microbot Medical provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Microbot Medical compares to historical norms and industry peers.
Latest Microbot Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Microbot Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Microbot Medical financial statement analysis. It represents the amount of money remaining after all of Microbot Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Microbot Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.44 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Microbot Net Income Regression Statistics
| Arithmetic Mean | (15,324,676) | |
| Coefficient Of Variation | (63.67) | |
| Mean Deviation | 8,093,150 | |
| Median | (10,813,635) | |
| Standard Deviation | 9,757,153 | |
| Sample Variance | 95.2T | |
| Range | 30M | |
| R-Value | 0.48 | |
| Mean Square Error | 78.2T | |
| R-Squared | 0.23 | |
| Significance | 0.05 | |
| Slope | 925,527 | |
| Total Sum of Squares | 1523.2T |
Microbot Net Income History
Other Fundumenentals of Microbot Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Microbot Medical Net Income component correlations
Microbot Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Net Income. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Microbot introduce new products? Factors like these will boost the valuation of Microbot Medical. Expected growth trajectory for Microbot significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Microbot Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Microbot Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Microbot Medical's market price to deviate significantly from intrinsic value.
Understanding that Microbot Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Microbot Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Microbot Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Microbot Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Microbot Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Microbot Medical.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Microbot Medical on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Microbot Medical or generate 0.0% return on investment in Microbot Medical over 90 days. Microbot Medical is related to or competes with Vivani Medical, InspireMD, Oramed Pharmaceuticals, Context Therapeutics, Cardiol Therapeutics, ZEN Graphene, and Ovid Therapeutics. Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of roboti... More
Microbot Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Microbot Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Microbot Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.95 | |||
| Information Ratio | 0.0032 | |||
| Maximum Drawdown | 30.11 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 8.64 |
Microbot Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbot Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Microbot Medical's standard deviation. In reality, there are many statistical measures that can use Microbot Medical historical prices to predict the future Microbot Medical's volatility.| Risk Adjusted Performance | 0.024 | |||
| Jensen Alpha | 0.0903 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | (1.72) |
Microbot Medical February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.024 | |||
| Market Risk Adjusted Performance | (1.71) | |||
| Mean Deviation | 3.52 | |||
| Semi Deviation | 3.73 | |||
| Downside Deviation | 3.95 | |||
| Coefficient Of Variation | 5196.38 | |||
| Standard Deviation | 5.03 | |||
| Variance | 25.26 | |||
| Information Ratio | 0.0032 | |||
| Jensen Alpha | 0.0903 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | (1.72) | |||
| Maximum Drawdown | 30.11 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 8.64 | |||
| Downside Variance | 15.6 | |||
| Semi Variance | 13.9 | |||
| Expected Short fall | (4.56) | |||
| Skewness | 1.47 | |||
| Kurtosis | 4.84 |
Microbot Medical Backtested Returns
Currently, Microbot Medical is very risky. Microbot Medical has Sharpe Ratio of 0.0274, which conveys that the firm had a 0.0274 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Microbot Medical, which you can use to evaluate the volatility of the firm. Please verify Microbot Medical's Mean Deviation of 3.52, downside deviation of 3.95, and Risk Adjusted Performance of 0.024 to check out if the risk estimate we provide is consistent with the expected return of 0.14%. Microbot Medical has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.0503, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Microbot Medical are expected to decrease at a much lower rate. During the bear market, Microbot Medical is likely to outperform the market. Microbot Medical right now secures a risk of 5.17%. Please verify Microbot Medical value at risk, and the relationship between the jensen alpha and skewness , to decide if Microbot Medical will be following its current price movements.
Auto-correlation | -0.04 |
Very weak reverse predictability
Microbot Medical has very weak reverse predictability. Overlapping area represents the amount of predictability between Microbot Medical time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Microbot Medical price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Microbot Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Microbot Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Microbot Medical reported net income of (11.44 Million). This is 103.35% lower than that of the Health Care Equipment & Supplies sector and 111.48% lower than that of the Health Care industry. The net income for all United States stocks is 102.0% higher than that of the company.
Microbot Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in net income category among its peers.
Microbot Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Microbot Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Microbot Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Microbot Medical's value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 34 K | Hilltop Holdings Inc | 2025-06-30 | 33.7 K | Susquehanna International Group, Llp | 2025-06-30 | 31.8 K | Scotia Capital Inc | 2025-06-30 | 22.8 K | Xtx Topco Ltd | 2025-06-30 | 17.2 K | Stifel Financial Corp | 2025-06-30 | 16.1 K | Beacon Capital Management, Llc | 2025-06-30 | 16 K | Citigroup Inc | 2025-06-30 | 14 K | American Century Companies Inc | 2025-06-30 | 12.7 K | Vanguard Group Inc | 2025-06-30 | 2.1 M | Atlantic Trust Group, Llc | 2025-06-30 | 612 K |
Microbot Fundamentals
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 55.06 M | ||||
| Shares Outstanding | 67.16 M | ||||
| Shares Owned By Institutions | 16.78 % | ||||
| Number Of Shares Shorted | 6.04 M | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 1.72 X | ||||
| EBITDA | (11.35 M) | ||||
| Net Income | (11.44 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 111 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 1.19 X | ||||
| Cash Flow From Operations | (8.83 M) | ||||
| Short Ratio | 5.29 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 20 | ||||
| Beta | 1.29 | ||||
| Market Capitalization | 134.32 M | ||||
| Total Asset | 6.03 M | ||||
| Retained Earnings | (90.94 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
| Net Asset | 6.03 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.